10. December 2018
Our product highlights, your reliable transglutaminase tools!
Read more
26. April 2018
Pressemitteilung: Dr. Falk Pharma und Zedira geben den Start der Phase 2a Wirksamkeitsstudie für ZED1227 zur Zöliakie-Therapie bekannt
Read more | Document
26. April 2018
Press release: Dr. Falk Pharma and Zedira announce start of the phase 2a proof of concept study of ZED1227 for the treatment of celiac disease
Read more | Document
15. January 2018
Zedira supports Gordon Research Conference
Read more | Document

News

Blog

Events